Bioequivalence testing of combined generic preparations to be made compulsory

The Korea Food and Drug Administration has unveiled its plan to introduce the mandatory bioequivalence testing of combined generic preparations to screen the clinical effectiveness of these medicines, when compared to original brand items.

The KFDA said in its report to the National Assembly that it will map out the plans to expand the coverage of bioequivalence testing by phase.

Under th...